VYGORIS Trademark

Trademark Overview


On Tuesday, January 16, 2018, a trademark application was filed for VYGORIS with the United States Patent and Trademark Office. The USPTO has given the VYGORIS trademark a serial number of 79231304. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2019. This trademark is owned by Vygoris Limited. The VYGORIS trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal, pharmaceutical, and veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; radioactive substances for medical purposes; dietary supplements for humans and animals; pharmaceutical preparations and medical substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, gen...
vygoris

General Information


Serial Number79231304
Word MarkVYGORIS
Filing DateTuesday, January 16, 2018
Status700 - REGISTERED
Status DateTuesday, July 30, 2019
Registration Number5815746
Registration DateTuesday, July 30, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2018

Trademark Statements


Description of MarkVYGORIS.
Goods and ServicesMedicinal, pharmaceutical, and veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; radioactive substances for medical purposes; dietary supplements for humans and animals; pharmaceutical preparations and medical substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; medicines and pharmaceuticals for use in oncology; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, available on prescription only; pharmaceutical preparations available on prescription only, namely, cytostatics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in urology; and pharmaceutical products for the prevention and treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSUBSTIPHARM
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressFR

Party NameVygoris Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameVygoris Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameVygoris Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, March 15, 2024CHANGE OF OWNER RECEIVED FROM IB
Friday, November 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 6, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, November 16, 2019FINAL DISPOSITION NOTICE SENT TO IB
Saturday, November 16, 2019FINAL DISPOSITION PROCESSED
Wednesday, October 30, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, June 20, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, January 10, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2018PUBLISHED FOR OPPOSITION
Saturday, December 8, 2018NOTIFICATION PROCESSED BY IB
Wednesday, November 21, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 21, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 1, 2018ASSIGNED TO LIE
Thursday, October 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 9, 2018REFUSAL PROCESSED BY IB
Friday, May 18, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 18, 2018REFUSAL PROCESSED BY MPU
Thursday, May 17, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 16, 2018NON-FINAL ACTION WRITTEN
Saturday, May 12, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, May 8, 2018ASSIGNED TO EXAMINER
Tuesday, May 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 3, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB